RGRX   $0.033  3.12% Market Closed

RegeneRx Biopharmaceuticals Inc
Total Cash 101.56K
totalCashPerShare 0.071
EBITDA
Total Debt 1.49M
quickRatio 0.056
currentRatio 0.068
Total Revenue 76.76K
debtToEquity
Revenue/Share 0.053
ROA -1.48503
ROE
grossProfits
freeCashflow -355.28K
operatingCashflow -823.75K
earningsGrowth
revenueGrowth 0.0
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -15.889111
profitMargins 0.0
enterpriseValue 1.39M
forwardPE
floatShares 806.79K
sharesOutstanding 1.50M
sharesShort 191.00
sharesShortPriorMonth 293.00
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.44%
heldPercentInstitutions 0.0
Short Ratio help_outline 0.16%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -2.608
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -1.69M
trailingEps -0.97%
forwardEps -0.01%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2017
institutionsCount 0
lastUpdated Oct. 16, 2024, 5:52 p.m.